Page last updated: 2024-10-31

nefazodone and Hyperlipidemias

nefazodone has been researched along with Hyperlipidemias in 2 studies

nefazodone: may be useful as an opiate adjunct

Hyperlipidemias: Conditions with excess LIPIDS in the blood.

Research Excerpts

ExcerptRelevanceReference
"Simvastatin is a hydroxymethyl glutaryl coenzyme A reductase inhibitor commonly used to treat patients with hyperlipidemia."5.32Rhabdomyolysis associated with simvastatin-nefazodone therapy. ( Monaghan, MS; Skrabal, MZ; Stading, JA, 2003)
"Simvastatin is a hydroxymethyl glutaryl coenzyme A reductase inhibitor commonly used to treat patients with hyperlipidemia."1.32Rhabdomyolysis associated with simvastatin-nefazodone therapy. ( Monaghan, MS; Skrabal, MZ; Stading, JA, 2003)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thompson, M1
Samuels, S1
Skrabal, MZ1
Stading, JA1
Monaghan, MS1

Other Studies

2 other studies available for nefazodone and Hyperlipidemias

ArticleYear
Rhabdomyolysis with simvastatin and nefazodone.
    The American journal of psychiatry, 2002, Volume: 159, Issue:9

    Topics: Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Interactions; Humans; Hype

2002
Rhabdomyolysis associated with simvastatin-nefazodone therapy.
    Southern medical journal, 2003, Volume: 96, Issue:10

    Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Interactions; Humans; Hydroxymet

2003